Terms: = Bone cancer AND CDC73, HRPT2, 79577, ENSG00000134371, HPT-JT, Q6P1J9, FLJ23316, C1orf28 AND Prognosis
7 results:
1. Parathyroid carcinoma: molecular therapeutic targets.
Marini F; Giusti F; Palmini G; Aurilia C; Donati S; Brandi ML
Endocrine; 2023 Sep; 81(3):409-418. PubMed ID: 37160841
[TBL] [Abstract] [Full Text] [Related]
2. Clinical and genetic analysis of atypical parathyroid adenoma compared with parathyroid carcinoma and benign lesions in a Chinese cohort.
Chen Y; Song A; Nie M; Jiang Y; Li M; Xia W; Wang O; Xing X
Front Endocrinol (Lausanne); 2023; 14():1027598. PubMed ID: 36777354
[TBL] [Abstract] [Full Text] [Related]
3. Successful Control of Hypercalcemia with Sorafenib, Evocalcet, and Denosumab Combination Therapy for Recurrent Parathyroid Carcinoma.
Makino H; Notsu M; Asayama I; Otani H; Morita M; Yamamoto M; Yamauchi M; Nakao M; Miyake H; Araki A; Uchino S; Kanasaki K
Intern Med; 2022 Nov; 61(22):3383-3390. PubMed ID: 35370235
[TBL] [Abstract] [Full Text] [Related]
4. Genetics and Epigenetics of Parathyroid Carcinoma.
Marini F; Giusti F; Palmini G; Perigli G; Santoro R; Brandi ML
Front Endocrinol (Lausanne); 2022; 13():834362. PubMed ID: 35282432
[TBL] [Abstract] [Full Text] [Related]
5. Do Patients With Atypical Parathyroid Adenoma Need Close Follow-up?
Saponaro F; Pardi E; Mazoni L; Borsari S; Torregrossa L; Apicella M; Frustaci G; Materazzi G; Miccoli P; Basolo F; Marcocci C; Cetani F
J Clin Endocrinol Metab; 2021 Oct; 106(11):e4565-e4579. PubMed ID: 34157106
[TBL] [Abstract] [Full Text] [Related]
6. Hyper Parathyroidisim Jaw Tumor Syndrome: A Rare Condition of Incongruous Features.
Redwin Dhas MP; Karthiga KS; Tatu JE; Eugenia SJ
Ethiop J Health Sci; 2017 May; 27(3):309-313. PubMed ID: 29217931
[TBL] [Abstract] [Full Text] [Related]
7. [Parathyroid carcinoma].
Vieira JG; Ohe MN; Hauache OM; Oliveira UM; Delana JM; Gonçalves A; Lazaretti-Castro M
Arq Bras Endocrinol Metabol; 2005 Oct; 49(5):811-5. PubMed ID: 16444365
[TBL] [Abstract] [Full Text] [Related]